, US National Institutes of Health. National Institute of Allergy and Infectious Diseases. Herd effect, 2015.

E. Vynnycky, An Introduction to Infectious Disease Modelling, p.369, 2010.

S. Riedel and . Edward, Jenner and the history of smallpox and vaccination, BUMC PROCEEDINGS, vol.18, pp.21-25, 2005.

R. Rappuoli, Bridging the knowledge gaps in vaccine design, Nature Biotechnology, vol.25, issue.12, pp.1361-1367, 2007.

S. Plotkin, History of vaccination, Proc Natl Acad Sci, vol.111, issue.34, pp.12283-12290, 2014.

U. , Department of Health & Human Services. Types of Vaccines, 2012.

R. Rappuoli, Vaccine discovery and translation of new vaccine technology, Lancet, vol.378, pp.360-68, 2011.

S. Plotkin, Vaccines: the fourth century, Clin Vaccine Immunol, vol.16, issue.12, pp.1709-1728, 2009.

B. Greenwood, The contribution of vaccination to global health: past, present and future, Phil. Trans. R. Soc. B, vol.369, 2014.

C. V. Adjuvants, , 2016.

L. Pickering, The Red Book through the Ages, Pediatrics, vol.132, issue.5, 2013.

U. S. Bureau, Statistical Abstract of the United States. 20th Century Statistics, 1999.

O. Levine, The future of immunization policy, implementation, and financing, Lancet, vol.378, pp.439-487, 2011.

G. The and . Alliance, Gavi's mission, 2017.

G. The and . Alliance, GAVI helps DTP3 coverage rise after stagnation, 2017.

. Pfizer, The Value of Vaccines in Disease Prevention, 2014.

W. G. Van-panhuis, Contagious Disease in the United States from 1888 to the Present, N Engl J Med, vol.369, issue.22, pp.2152-2160, 2013.

J. Ehreth, The global value of vaccination, Vaccine, vol.21, issue.7-8, pp.596-600, 2003.

U. Who and W. Bank, State of the world's vaccines and immunization, 3 rd edition. Geneva, World Health Organization, 2009. 21. WHO. World Immunization Week, 2013.

F. Zhou, Economic Evaluation of the Routine Childhood Immunization Program in the United States, Pediatrics, vol.133, issue.4, 2009.

, Vaccines Work: Key Facts and Figures, 2010.

. Horton-2011, The vaccine paradox, Lancet, vol.378, issue.9788, pp.296-304, 2011.

A. Burton, WHO and UNICEF estimates of national infant immunization coverage: methods and processes, Bull World Health Organ, vol.87, pp.535-541, 2009.

, Vaccines and Biologicals-data, statistics and graphs, 2016.

G. The and . Alliance, Accessed online at <http://www.gavi.org/support/apply/countries-eligible-for-support> 30. WHO. Global Vaccine Action Plan, 2011.

, Global routine vaccination coverage, 2015.

. Thepharmaletter and . Golden, Age of pharmaceutical industry, 1999.

J. Cucurella, The worldwide vaccine market: what are the main challenges with a full conversion toward pre-filled syringes? Professional Thesis, ESSEC Business School, p.63, 2009.

J. Smith, Vaccine production, distribution, access, and uptake, Lancet, vol.378, pp.428-466, 2011.

, Xerfi Global. Pharmaceutical Groups-World, 2016.

, Mordor Intelligence. Preventive Vaccines Market-Trends and Forecasts, pp.2017-2022, 2017.

. Evaluatepharma, , p.2022, 2017.

E. Moxon, The next decade of vaccines: societal and scientific challenges, Lancet, vol.378, pp.348-59, 2011.

. Transparency-market-research, Vaccine Market-Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014.

. Sanofi, , 2016.

. Glaxosmithkline, , 2016.

&. Merck and . Co, , 2016.

H. J. Larson, Addressing the vaccine confidence gap, Lancet, vol.378, issue.9790, pp.526-561, 2011.

G. A. Poland, Understanding those who do not understand: a brief review of the antivaccine movement, Vaccine, vol.19, pp.2440-2445, 2001.

M. E. Macdonald, Vaccine hesitancy: Definition, scope and determinants, Vaccine, vol.33, issue.34, pp.4161-4165, 2015.

J. Matjasko, Applying Behavioral Economics to Public Health Policy, Am J Prev Med, vol.50, issue.5, pp.13-19, 2016.

R. T. Chen, Vaccine risks: real, perceived and unknown, Vaccine, vol.17, issue.3, pp.41-47, 1999.

D. Kahneman, Thinking, Fast and Slow, 2011.

F. Chen, Applying lessons from behavioral economics to increase flu vaccination rates, Health Promot Int, p.31, 2016.

T. Kuran, Public Law and Legal Theory Working Papers, 2007.

O. Yaqub, Attitude to vaccination: a critical review, Soc Sci Med, vol.112, pp.1-11, 2014.

E. Hak, Negative attitude of highly educated parents and health care workers towards future vaccinations in the Dutch childhood vaccination program, Vaccine, vol.23, issue.24, pp.3103-3110, 2005.

G. Gefenaite, Comparatively low attendance during Human Papillomavirus catch-up vaccination among teenage girls in the Netherlands: Insights from a behavioral survey among parents, BMC Public Health, vol.12, p.498, 2012.

R. G. Peters, The Determinants of Trust and Credibility in Environmental Risk Communication: An Empirical Study, Risk Anal, vol.17, issue.1, pp.43-54, 1997.

S. Blume, Anti-vaccination movements and their interpretations, Soc Sci Med, vol.62, issue.3, pp.628-670, 2006.

P. Paterson, Vaccine hesitancy and healthcare providers, Vaccine, vol.34, issue.52, pp.6700-6706, 2016.

E. M. Mccarthy, Knowledge, attitudes, and clinical practice of rheumatologists in vaccination of the at-risk rheumatology patient population, J Clin Rheumatol, vol.18, issue.5, pp.237-278, 2012.

E. Karafillakis, Vaccine hesitancy among healthcare workers in Europe: A qualitative study, Vaccine, vol.34, issue.41, pp.5013-5020, 2016.

P. Verger, Vaccine Hesitancy Among General Practitioners and Its Determinants During Controversies: A National Cross-sectional Survey in France, EBioMedicine, vol.2, issue.8, pp.891-898, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01816807

, Association E3M. For aluminium-free vaccines, 2017.

. Iccr-website, Accessed online at <http://www.iccr.org/> 65. The Economist. Vaccines, A smarter jab, 2010.

, Vaccines Are Profitable, So What?, 2015.

G. J. Nowak, Addressing vaccine hesitancy: The potential value of commercial and social marketing principles and practices, Vaccine, vol.33, issue.34, pp.4204-4215, 2015.

D. Bach, What every CEO needs to know about nonmarket strategy. MIT Sloan Management Review, 2010.

&. Mckinsey and . Company, Beyond corporate social responsibility: Integrated external engagement, 2013.

J. Boddewyn, Understanding and Advancing the Concept of, Nonmarket'. Business & Society, vol.42, issue.3, pp.297-327, 2003.
DOI : 10.1177/0007650303257504

&. Mckinsey and . Company, Tackling sociopolitical issues in hard times: McKinsey Global Survey results, 2009.

M. Mello, Pharmaceutical Companies' Role in State Vaccination Policymaking: The Case of Human Papillomavirus Vaccination, Am J Public Health, vol.102, issue.5, pp.893-898, 2012.

M. Msf, Welcomes GSK's Decision to Lower Price of Pneumonia Vaccine for Some of the World's Most Vulnerable Children, 2016.

M. Msf, welcomes Pfizer's pneumonia vaccine price reduction for children in humanitarian emergencies, 2016.